Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.
Identifieur interne : 001327 ( PubMed/Corpus ); précédent : 001326; suivant : 001328Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.
Auteurs : Shibo Jiang ; Lu Lu ; Qi Liu ; Wei Xu ; Lanying DuSource :
- Emerging microbes & infections [ 2222-1751 ] ; 2012.
Abstract
A number of emerging and re-emerging viruses have caused epidemics or pandemics of infectious diseases leading to major devastations throughout human history. Therefore, developing effective and safe vaccines against these viruses is clearly important for the protection of at-risk populations. Our previous studies have shown that the receptor-binding domain (RBD) in the spike protein of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) is a key target for the development of SARS vaccines. In this review, we highlight some key advances in the development of antiviral vaccines targeting the RBDs of spike proteins of emerging and re-emerging viruses, using SARS-CoV, influenza virus, Hendra virus (HeV) and Nipah virus (NiV) as examples.
DOI: 10.1038/emi.2012.1
PubMed: 26038424
Links to Exploration step
pubmed:26038424Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.</title><author><name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China ; Lindsley F. Kimball Research Institute, New York Blood Center , New York, NY 10065, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lu, Lu" sort="Lu, Lu" uniqKey="Lu L" first="Lu" last="Lu">Lu Lu</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China.</nlm:affiliation></affiliation></author><author><name sortKey="Liu, Qi" sort="Liu, Qi" uniqKey="Liu Q" first="Qi" last="Liu">Qi Liu</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China ; Department of Medical Microbiology and Immunology, School of Basic Medicine, Dali University , Dali 671000, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xu, Wei" sort="Xu, Wei" uniqKey="Xu W" first="Wei" last="Xu">Wei Xu</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China.</nlm:affiliation></affiliation></author><author><name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name><affiliation><nlm:affiliation>Lindsley F. Kimball Research Institute, New York Blood Center , New York, NY 10065, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:26038424</idno><idno type="pmid">26038424</idno><idno type="doi">10.1038/emi.2012.1</idno><idno type="wicri:Area/PubMed/Corpus">001327</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001327</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.</title><author><name sortKey="Jiang, Shibo" sort="Jiang, Shibo" uniqKey="Jiang S" first="Shibo" last="Jiang">Shibo Jiang</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China ; Lindsley F. Kimball Research Institute, New York Blood Center , New York, NY 10065, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lu, Lu" sort="Lu, Lu" uniqKey="Lu L" first="Lu" last="Lu">Lu Lu</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China.</nlm:affiliation></affiliation></author><author><name sortKey="Liu, Qi" sort="Liu, Qi" uniqKey="Liu Q" first="Qi" last="Liu">Qi Liu</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China ; Department of Medical Microbiology and Immunology, School of Basic Medicine, Dali University , Dali 671000, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xu, Wei" sort="Xu, Wei" uniqKey="Xu W" first="Wei" last="Xu">Wei Xu</name><affiliation><nlm:affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China.</nlm:affiliation></affiliation></author><author><name sortKey="Du, Lanying" sort="Du, Lanying" uniqKey="Du L" first="Lanying" last="Du">Lanying Du</name><affiliation><nlm:affiliation>Lindsley F. Kimball Research Institute, New York Blood Center , New York, NY 10065, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Emerging microbes & infections</title><idno type="ISSN">2222-1751</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A number of emerging and re-emerging viruses have caused epidemics or pandemics of infectious diseases leading to major devastations throughout human history. Therefore, developing effective and safe vaccines against these viruses is clearly important for the protection of at-risk populations. Our previous studies have shown that the receptor-binding domain (RBD) in the spike protein of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) is a key target for the development of SARS vaccines. In this review, we highlight some key advances in the development of antiviral vaccines targeting the RBDs of spike proteins of emerging and re-emerging viruses, using SARS-CoV, influenza virus, Hendra virus (HeV) and Nipah virus (NiV) as examples. </div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26038424</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2222-1751</ISSN><JournalIssue CitedMedium="Print"><Volume>1</Volume><Issue>8</Issue><PubDate><Year>2012</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Emerging microbes & infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.</ArticleTitle><Pagination><MedlinePgn>e13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/emi.2012.1</ELocationID><Abstract><AbstractText>A number of emerging and re-emerging viruses have caused epidemics or pandemics of infectious diseases leading to major devastations throughout human history. Therefore, developing effective and safe vaccines against these viruses is clearly important for the protection of at-risk populations. Our previous studies have shown that the receptor-binding domain (RBD) in the spike protein of severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) is a key target for the development of SARS vaccines. In this review, we highlight some key advances in the development of antiviral vaccines targeting the RBDs of spike proteins of emerging and re-emerging viruses, using SARS-CoV, influenza virus, Hendra virus (HeV) and Nipah virus (NiV) as examples. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Shibo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China ; Lindsley F. Kimball Research Institute, New York Blood Center , New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China ; Department of Medical Microbiology and Immunology, School of Basic Medicine, Dali University , Dali 671000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>MOE/MOH Key Laboratory of Medical Molecular Virology, Shanghai Medical College and Institute of Medical Microbiology, Fudan University , Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Lanying</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Lindsley F. Kimball Research Institute, New York Blood Center , New York, NY 10065, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI068002</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AI088449</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hendra virus</Keyword><Keyword MajorTopicYN="N">Nipah virus</Keyword><Keyword MajorTopicYN="N">SARS-CoV</Keyword><Keyword MajorTopicYN="N">influenza virus</Keyword><Keyword MajorTopicYN="N">receptor-binding domain</Keyword><Keyword MajorTopicYN="N">spike protein</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>03</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>03</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>03</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26038424</ArticleId><ArticleId IdType="doi">10.1038/emi.2012.1</ArticleId><ArticleId IdType="pmc">PMC3630917</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Virol. 2006 Jan;80(2):891-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16378991</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Jul 7-13;304(5921):76-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6191220</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Apr 21;6(4):e1000049</Citation><ArticleIdList><ArticleId IdType="pubmed">19381279</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2004 Dec;10(12 Suppl):S82-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15577936</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2004 Jun;203(2):622-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Nov;81(21):12029-39</Citation><ArticleIdList><ArticleId IdType="pubmed">17715238</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Jan 15;180(2):948-56</Citation><ArticleIdList><ArticleId IdType="pubmed">18178835</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation><ArticleIdList><ArticleId IdType="pubmed">14651994</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2010 Apr 16;328(5976):357-60</Citation><ArticleIdList><ArticleId IdType="pubmed">20339031</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2009 Oct 23;27(45):6276-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19840660</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2009 Oct 10;393(1):144-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19683779</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 Nov;85(21):11048-57</Citation><ArticleIdList><ArticleId IdType="pubmed">21865387</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Aug;84(16):8275-86</Citation><ArticleIdList><ArticleId IdType="pubmed">20519402</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Aug 5;29(34):5623-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21689706</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15210961</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15530413</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 May 17;108(20):8426-31</Citation><ArticleIdList><ArticleId IdType="pubmed">21536871</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2010 Apr;23(2):181-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20373998</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Jun;79(11):6690-702</Citation><ArticleIdList><ArticleId IdType="pubmed">15890907</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 Feb;85(3):1246-56</Citation><ArticleIdList><ArticleId IdType="pubmed">21084473</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2010 Mar 19;393(4):614-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20152806</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17175-80</Citation><ArticleIdList><ArticleId IdType="pubmed">19805083</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 2002 Oct 1;21(19):5017-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12356718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2005 Sep 16;309(5742):1864-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16166518</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2004 Apr 30;304(5671):659-61</Citation><ArticleIdList><ArticleId IdType="pubmed">15118129</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2005 Apr 25;335(1):34-45</Citation><ArticleIdList><ArticleId IdType="pubmed">15823604</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2010 Oct;84(19):9831-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20660198</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Dec 22;5(12):e15559</Citation><ArticleIdList><ArticleId IdType="pubmed">21203523</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2006 May 15;176(10):6085-92</Citation><ArticleIdList><ArticleId IdType="pubmed">16670317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2011 Oct 19;3(105):105ra103</Citation><ArticleIdList><ArticleId IdType="pubmed">22013123</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1986 Sep;5(9):2371-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3023071</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Mar 15;197(6):846-53</Citation><ArticleIdList><ArticleId IdType="pubmed">18271743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2009 Mar;7(3):226-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19198616</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 Jun;80(12):5757-67</Citation><ArticleIdList><ArticleId IdType="pubmed">16731915</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1998 Oct 30;282(5390):938-41</Citation><ArticleIdList><ArticleId IdType="pubmed">9794763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Oct 25;362(9393):1353-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14585636</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Sep;68(9):5403-10</Citation><ArticleIdList><ArticleId IdType="pubmed">7520090</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2009 Feb;83(4):2011-4</Citation><ArticleIdList><ArticleId IdType="pubmed">19052094</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):797-801</Citation><ArticleIdList><ArticleId IdType="pubmed">15642942</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81</Citation><ArticleIdList><ArticleId IdType="pubmed">15474494</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2008 Mar 20;26(13):1644-51</Citation><ArticleIdList><ArticleId IdType="pubmed">18289745</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Nov;78(22):12672-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15507655</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2001 Apr;3(4):279-87</Citation><ArticleIdList><ArticleId IdType="pubmed">11334745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2009 Jun 18;459(7249):931-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19525932</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Mar;79(5):2678-88</Citation><ArticleIdList><ArticleId IdType="pubmed">15708987</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2010 Nov 12;7:312</Citation><ArticleIdList><ArticleId IdType="pubmed">21073718</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(6):e20928</Citation><ArticleIdList><ArticleId IdType="pubmed">21687743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2004 Mar 20;363(9413):938-47</Citation><ArticleIdList><ArticleId IdType="pubmed">15043961</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10652-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15998730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 Dec;80(24):12293-302</Citation><ArticleIdList><ArticleId IdType="pubmed">17005664</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2009 Mar;5(3):e1000350</Citation><ArticleIdList><ArticleId IdType="pubmed">19300497</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21</Citation><ArticleIdList><ArticleId IdType="pubmed">21825125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Assoc Thai. 2006 Sep;89 Suppl 3:S218-33</Citation><ArticleIdList><ArticleId IdType="pubmed">17722309</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Jul 22;5(7):e11694</Citation><ArticleIdList><ArticleId IdType="pubmed">20661476</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Feb;77(4):2530-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12551991</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2011 Feb;24(1):45-56</Citation><ArticleIdList><ArticleId IdType="pubmed">21319978</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19423869</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2005 Mar 30;334(1):74-82</Citation><ArticleIdList><ArticleId IdType="pubmed">15749124</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 2007 Jul 20;359(1):174-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17533109</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2006 Sep 15;353(1):6-16</Citation><ArticleIdList><ArticleId IdType="pubmed">16793110</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1999 Sep 11;354(9182):916-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10489954</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2006 Apr 21;312(5772):404-10</Citation><ArticleIdList><ArticleId IdType="pubmed">16543414</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Jun;81(11):5893-901</Citation><ArticleIdList><ArticleId IdType="pubmed">17376907</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust Vet J. 1998 Dec;76(12):813-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9972433</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2004 Feb 13;303(5660):944-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14963300</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(4):e35421</Citation><ArticleIdList><ArticleId IdType="pubmed">22536382</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2009 Mar;83(6):2553-62</Citation><ArticleIdList><ArticleId IdType="pubmed">19109379</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2011 May 21;8:251</Citation><ArticleIdList><ArticleId IdType="pubmed">21600020</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Dec;81(23):12911-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17881439</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1356-61</Citation><ArticleIdList><ArticleId IdType="pubmed">14745020</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15496474</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Jan 27;6(1):e16555</Citation><ArticleIdList><ArticleId IdType="pubmed">21304591</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation><ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2003 Dec 12;115(6):652-3</Citation><ArticleIdList><ArticleId IdType="pubmed">14675530</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2007 Apr;170(4):1136-47</Citation><ArticleIdList><ArticleId IdType="pubmed">17392154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001327 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001327 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26038424
|texte= Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26038424" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |